143 related articles for article (PubMed ID: 23880347)
1. Plasma cis-vaccenic acid and risk of heart failure with antecedent coronary heart disease in male physicians.
Djoussé L; Matsumoto C; Hanson NQ; Weir NL; Tsai MY; Gaziano JM
Clin Nutr; 2014 Jun; 33(3):478-82. PubMed ID: 23880347
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell membrane concentration of cis-palmitoleic and cis-vaccenic acids and risk of coronary heart disease.
Djoussé L; Matthan NR; Lichtenstein AH; Gaziano JM
Am J Cardiol; 2012 Aug; 110(4):539-44. PubMed ID: 22579341
[TBL] [Abstract][Full Text] [Related]
3. Relation between plasma phospholipid oleic acid and risk of heart failure.
Morin SJ; Gaziano JM; Djoussé L
Eur J Nutr; 2018 Dec; 57(8):2937-2942. PubMed ID: 29094199
[TBL] [Abstract][Full Text] [Related]
4. Plasma phospholipid concentration of cis-palmitoleic acid and risk of heart failure.
Djoussé L; Weir NL; Hanson NQ; Tsai MY; Gaziano JM
Circ Heart Fail; 2012 Nov; 5(6):703-9. PubMed ID: 23065037
[TBL] [Abstract][Full Text] [Related]
5. Plasma phospholipid trans fatty acids and risk of heart failure.
Tokede OA; Petrone AB; Hanson NQ; Tsai MY; Weir NA; Glynn RJ; Gaziano JM; Djoussé L
Am J Clin Nutr; 2013 Apr; 97(4):698-705. PubMed ID: 23446892
[TBL] [Abstract][Full Text] [Related]
6. Plasma phospholipid saturated fatty acids and heart failure risk in the Physicians' Health Study.
Matsumoto C; Hanson NQ; Tsai MY; Glynn RJ; Gaziano JM; Djoussé L
Clin Nutr; 2013 Oct; 32(5):819-23. PubMed ID: 23473794
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of n-3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-based (JPHC) study.
Hamazaki K; Iso H; Eshak ES; Ikehara S; Ikeda A; Iwasaki M; Hamazaki T; Tsugane S;
Atherosclerosis; 2018 May; 272():226-232. PubMed ID: 29277442
[TBL] [Abstract][Full Text] [Related]
8. Serum fatty acids and the risk of coronary heart disease.
Simon JA; Hodgkins ML; Browner WS; Neuhaus JM; Bernert JT; Hulley SB
Am J Epidemiol; 1995 Sep; 142(5):469-76. PubMed ID: 7677125
[TBL] [Abstract][Full Text] [Related]
9. Association between adiponectin and heart failure risk in the physicians' health study.
Djoussé L; Wilk JB; Hanson NQ; Glynn RJ; Tsai MY; Gaziano JM
Obesity (Silver Spring); 2013 Apr; 21(4):831-4. PubMed ID: 23712986
[TBL] [Abstract][Full Text] [Related]
10. Plasma phospholipid fatty acid biomarkers of dietary fat quality and endogenous metabolism predict coronary heart disease risk: a nested case-control study within the Women's Health Initiative observational study.
Matthan NR; Ooi EM; Van Horn L; Neuhouser ML; Woodman R; Lichtenstein AH
J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25122663
[TBL] [Abstract][Full Text] [Related]
11. Plasma and dietary omega-3 fatty acids, fish intake, and heart failure risk in the Physicians' Health Study.
Wilk JB; Tsai MY; Hanson NQ; Gaziano JM; Djoussé L
Am J Clin Nutr; 2012 Oct; 96(4):882-8. PubMed ID: 22952185
[TBL] [Abstract][Full Text] [Related]
12. Plasma galectin 3 and heart failure risk in the Physicians' Health Study.
Djoussé L; Matsumoto C; Petrone A; Weir NL; Tsai MY; Gaziano JM
Eur J Heart Fail; 2014 Mar; 16(3):350-4. PubMed ID: 24464746
[TBL] [Abstract][Full Text] [Related]
13. Plasma vitamin D-binding protein and risk of heart failure in male physicians.
Petrone AB; Weir NL; Steffen BT; Tsai MY; Gaziano JM; Djoussé L
Am J Cardiol; 2013 Sep; 112(6):827-30. PubMed ID: 23735647
[TBL] [Abstract][Full Text] [Related]
14. Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.
Lee Y; Lai HTM; de Oliveira Otto MC; Lemaitre RN; McKnight B; King IB; Song X; Huggins GS; Vest AR; Siscovick DS; Mozaffarian D
J Am Heart Assoc; 2020 Feb; 9(4):e014119. PubMed ID: 32020839
[TBL] [Abstract][Full Text] [Related]
15. Association Between Fatty Acids of Blood Cell Membranes and Incidence of Coronary Heart Disease.
Papandreou C; Sala-Vila A; Galié S; Muralidharan J; Estruch R; Fitó M; Razquin C; Corella D; Ros E; Timiraos J; Lapetra J; Serra-Majem L; Carlos S; Castañer O; Asensio EM; Salas-Salvadó J; Bulló M
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):819-825. PubMed ID: 30727755
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality.
Øie E; Ueland T; Dahl CP; Bohov P; Berge C; Yndestad A; Gullestad L; Aukrust P; Berge RK
J Intern Med; 2011 Sep; 270(3):263-72. PubMed ID: 21466599
[TBL] [Abstract][Full Text] [Related]
17. Circulating Very-Long-Chain Saturated Fatty Acids and Incident Coronary Heart Disease in US Men and Women.
Malik VS; Chiuve SE; Campos H; Rimm EB; Mozaffarian D; Hu FB; Sun Q
Circulation; 2015 Jul; 132(4):260-8. PubMed ID: 26048094
[TBL] [Abstract][Full Text] [Related]
18. Cyclic Guanosine Monophosphate and Risk of Incident Heart Failure and Other Cardiovascular Events: the ARIC Study.
Zhao D; Guallar E; Vaidya D; Ndumele CE; Ouyang P; Post WS; Lima JA; Ying W; Kass DA; Hoogeveen RC; Shah SJ; Subramanya V; Michos ED
J Am Heart Assoc; 2020 Jan; 9(2):e013966. PubMed ID: 31928156
[TBL] [Abstract][Full Text] [Related]
19. Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study.
Khaw KT; Friesen MD; Riboli E; Luben R; Wareham N
PLoS Med; 2012; 9(7):e1001255. PubMed ID: 22802735
[TBL] [Abstract][Full Text] [Related]
20. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study.
Wu JH; Lemaitre RN; Imamura F; King IB; Song X; Spiegelman D; Siscovick DS; Mozaffarian D
Am J Clin Nutr; 2011 Aug; 94(2):431-8. PubMed ID: 21697077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
